Brincidofovir

Brincidofovir Overview

Reviewed: October 19, 2014
Updated: 

Brincidofovir is an oral antiviral drug being developed as a potential prevention or treatment for life-threatening viral diseases. It works by keeping viruses from creating additional copies of themselves.

Brincidofovir is in Phase 3 clinical testing against cytomegalovirus (CMV) and adenovirus (AdV) but has been given to patients with many other life-threatening viral infections through an Expanded Access trial that was completed in 2012.  The safety database of over 1000 individuals exposed to BCV has supported progression into Phase 3 trials.

Patients in the U.S. have been treated with brincidofovir for Ebola Virus Disease at the request of treating physicians. Emergency Investigational New Drug Applications (EINDs) have been approved by the U.S. Food and Drug Administration (FDA) for the use of brincidofovir in patients with confirmed Ebola Virus Disease. 

How was your experience with ?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking ?

What are you taking for?

Choose one
  • Other

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend to a friend?

Brincidofovir Drug Class

Back to Top

Brincidofovir is part of the drug class:

Contributors

All RxWiki content including health news, medication pages, and condition pages published prior to February 2023, was written and maintained by on-staff pharmacists. Please be advised that this content is no longer actively maintained and may now contain outdated information. If you have any questions regarding previously published content, please contact support@rxwiki.com.

References
"Discovery and Clinical Trials: Brincidofovir (CMX001)", Chimerix, Inc. 2014.